Jefferies Financial Group reported Q3 results on September 28 and faces a second print on October 2, with the stock at $46.52 after shedding 12% over the past month and the Street already moving targets lower on the day of the data.
The analyst reaction on September 29 was one of the more concentrated target-trimming sessions of the year. Four firms filed revisions within hours of each other, all in the same direction. Goldman Sachs cut its target from $67 to $57 while keeping Buy. Morgan Stanley edged from $50 to $49 at Equal-Weight. Oppenheimer, the most bullish voice on the stock, trimmed from $76 to $71 but held Outperform. BMO Capital came in at $50, down from $57, at Market Perform. The mean target across all analysts now stands at $56.67, roughly 22% above the current price. That gap is wide, but the direction of travel is clear: the Street is marking down its optimism, not abandoning it. The price-to-book multiple has compressed by roughly 12% over the past 30 days to 0.85, meaning the stock now trades below book value, a level that has historically attracted attention for financial stocks but also signals genuine uncertainty about near-term earnings power.
Positioning around the print is notably relaxed relative to what prevailed through August. The put/call ratio has continued easing, reaching 2.02 on September 29, now 1.5 standard deviations below its 20-day average of 2.38. As recently as late August, the PCR was running above 2.8, the highest level of the past year. The unwinding of that hedging pressure suggests investors removed protection into the September 28 result rather than adding it ahead of the October 2 release. The lending market tells the same story: borrow availability has eased back to over 5,200% of shares on loan, meaning roughly 52 shares remain available to borrow for every one already lent out. Cost to borrow has fallen 41% over the past week to 0.37%. Short interest at 3.4% of free float is not the angle here.
The ownership story remains the most structurally interesting fact about JEF. Sumitomo Mitsui Financial Group holds 21.3% of shares outstanding after adding 5.9 million shares at $54.86 in July, a transaction worth more than $324 million. The stock closed September 29 at $46.52, leaving Sumitomo's most recent purchase well underwater. CEO Richard Handler holds a further 6.7% of the company and added shares in late August at $53.09 through a company award. The combined message from the two largest insiders, one external and strategic, one internal and operational, is that both parties were comfortable accumulating at prices 14% to 18% above where the stock trades today. Wikipedia attention data from Wikimedia Foundation is running at a z-score of 2.07 against the stock's own 90-day history, suggesting retail interest in the name has picked up noticeably in the past week.
After the September 28 print, the stock fell 2.4% the following day. The June 24 result produced a 13% single-day drop and a 15% five-day loss, still the most violent recent reaction in the earnings history. The June 29 result, by contrast, delivered a 1.8% gain on the day and a nearly 12% five-day advance. The range of outcomes is wide, which is part of why the PCR ran so elevated through the summer.
What to watch on October 2 is whether the Q3 revenue mix, particularly capital markets activity, justifies the multiple compression the Street has already priced in, or whether the bear case around fraud losses and litigation-linked earnings uncertainty forces another round of target reductions.
See the live data behind this article on ORTEX.
Open JEF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
